Table 2.
Treatment details of patients with autoimmune hepatitis
|
Years of medication use n (%)a |
Patients n (%) |
Years of use, median (range) | Dose mg/d median (range) | |
|---|---|---|---|---|
| Predniso(lo)ne | 3767 (57) | 429 (90) | 7 (1‐39) | 8 (1.67‐33.75) |
| Budesonide | 449 (7) | 85 (18) | 4 (1‐16) | 6 (1‐12) |
| Azathioprine | 4541 (68) | 392 (82) | 12 (1‐34) | 73 (4‐500) |
| Mycophenolate mofetil | 195 (3) | 33 (7) | 6 (1‐15) | 1000 (50‐4000) |
| Ciclosporin | 66 (1) | 11 (2) | 6 (1‐14) | 138 (13‐400) |
| Tacrolimus | 28 (0) | 6 (1) | 5 (1‐8) | 5 (0.7‐12.0) |
| Mercaptopurine | 60 (1) | 15 (3) | 2 (1‐21) | 50 (1‐100) |
| Tioguanine | 35 (1) | 9 (2) | 2 (1‐10) | 18 (3‐50) |
| Allopurinol | 39 (1) | 14 (3) | 3 (1‐6) | 100 (50‐100) |
| Ursodeoxycholic acid | 1661 (25) | 164 (34) | 11 (1‐28) | 825 (50‐1800) |
a
The total patient‐years was 6634.